**Susan Mesco, Head of Investor Relations**
Thank you. Good afternoon, everyone. Welcome to today’s conference call to discuss our third quarter 2025 financial results.
Joining me are Frank Lee, Chief Executive Officer; Brendan Teehan, Chief Commercial Officer; and Shawn Cross, Chief Financial Officer. Jonathan Slonin, our Chief Medical Officer, is also here for our question-and-answer session.
Before we begin, let me remind you that this call will include forward-looking statements subject to the safe harbor provisions of federal securities laws. Such statements represent our judgment as of today and may involve risks and uncertainties. This may cause our actual results, performance, or achievements to differ materially.
For information concerning risk factors that could affect the company, please refer to our filings with the SEC. These are available from the SEC or the Pacira website.
Lastly, as a reminder, we will be discussing non-GAAP financial measures on today’s call. A description of these metrics, along with our reconciliation to GAAP, can be found in the news release issued earlier this afternoon.
With that, I will now turn the call over to Frank Lee.
https://seekingalpha.com/article/4840146-pacira-biosciences-inc-pcrx-q3-2025-earnings-call-transcript?source=feed_all_articles